Trial Details

COMPLETED
Basic Information
Clinical ID c911
Identifier NCT00421642
Trial Title Open-Label Adalimumab for Ulcerative Colitis Patients
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Adalimumab
Participant Information
Sponsor Mayo Clinic
City Scottsdale
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-10-06
Primary Completion Date 2025-04-08
Completion Date 2025-04-08